As the healthcare environment throughout the globe has turned the focus onto cost minimization, economic analyses performed alongside clinical trials have become essential in obtaining adequate reimbursement for medical devices and gaining market share. Manufacturers are now looking to clinical research teams to support reimbursement through the inclusion of economic considerations throughout clinical research – starting at the earliest stages of development in order to support the economic value proposition of new and existing products. As patients, payers and healthcare providers continue to demand lower cost, yet highly innovative products, it is essential that clinical research and reimbursement strategies align to meet global economic stakeholder needs.

Trial design considerations to support reimbursement and provider economics

Impact of recent US health policy changes on clinical trial design and execution

Practical considerations in economic evidence development and execution